本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kymera Therapeutics, Inc.

87.71
+1.571.82%
盘后87.710.00000.00%18:28 EDT
成交量:58.74万
成交额:5,157.76万
市值:71.61亿
市盈率:-23.77
高:88.45
开:87.75
低:87.06
收:86.14
52周最高:103.00
52周最低:25.50
股本:8,164.24万
流通股本:5,462.66万
量比:1.23
换手率:1.08%
股息:- -
股息率:- -
每股收益(TTM):-3.6900
每股收益(LYR):-3.6900
净资产收益率:-25.78%
总资产收益率:-15.87%
市净率:4.53
市盈率(LYR):-23.77

数据加载中...

2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/20

重要事件披露

Form 8-K - Current report
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/08

重要事件披露

Form 8-K - Current report
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities